Skip to content
ClinCalc Pro
Menu
Combined calcium + vitamin D

Ergocalciferol with calcium lactate and calcium phosphate

Brand names: Calcium with Vitamin D

This is a combination preparation of ergocalciferol (vitamin D2) with calcium lactate and calcium phosphate, used to treat or prevent combined calcium and vitamin D deficiency.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Ergocalciferol is converted to active vitamin D metabolites that enhance intestinal absorption of calcium and phosphate, while the calcium salts directly supply elemental calcium for bone mineralisation.

Prescribing in practice

  • Avoid in hypercalcaemia, hypercalciuria and conditions with vitamin D oversensitivity, as the combined calcium and vitamin D load can precipitate or worsen hypercalcaemia.
  • Calcium salts reduce absorption of oral tetracyclines, levothyroxine, bisphosphonates and some quinolones, so separate administration times.
  • Use with caution in renal impairment, sarcoidosis and a history of calcium-containing renal stones.

Monitoring

Monitor serum and urinary calcium periodically, especially in renal impairment or where high doses are used long term.

Counselling the patient

  • Take other medicines such as thyroid tablets or certain antibiotics at a different time from this supplement.
  • Report nausea, constipation, excessive thirst or passing large amounts of urine, which can indicate high calcium.
  • Do not take additional calcium or vitamin D products without advice.

Evidence & guidelines

Combined calcium and vitamin D supplementation is supported by NICE guidance for correcting deficiency and as an adjunct in osteoporosis management.

Reference: NICE NG121; Royal Osteoporosis Society; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.